Role of RNF213 polymorphism in defining quasi-moyamoya disease and definitive moyamoya disease.
Ishisaka E, Watanabe A, Murai Y, Shirokane K, Matano F, Tsukiyama A, Baba E, Nakagawa S, Tamaki T, Mizunari T, Tanikawa R, Morita A.
Ishisaka E, et al. Among authors: shirokane k.
Neurosurg Focus. 2021 Sep;51(3):E2. doi: 10.3171/2021.5.FOCUS21182.
Neurosurg Focus. 2021.
PMID: 34469872